Identification of viable myocardium early after acute myocardial infarction using closed-loop arbutamine echocardiography: comparison with positron emission tomography
[en] Objective -This study sought to evaluate the safety and efficacy of arbutamine echocardiography in identifying contractile reserve and predicting functional improvement early after acute myocardial infarction (AMI). Methods and results - Seventeen patients with first AMI underwent arbutamine echocardiography 48 to 96 hours after AMI. Arbutamine was infused by a closed-loop delivery device. The heart rate slope was 4 beats/min and the heart rate target was 20 beats/min above baseline heart rate. A follow-up echocardiogram was obtained one month later. N- 13 ammonia and F- 18 FDG positron emission tomographic (PET) imaging were performed 6 2 days after AMI, before coronary angiography. Mean duration of arbutamine infusion was 6 2 min. There was no complication and there were no major side effects. Myocardial viability was identified with PET in 15 of the 17 patients. Contractile reserve was observed in 10 patients during arbutamine infusion. Functional recovery was identified in 12 patients. Sensitivity, specificity and accuracy of PET and arbutamine echocardiography for predicting functional recovery were 100%, 40%, 76% and 67%, 80%, 84%, respectively. Conclusions - Low-dose arbutamine stress testing is safe early after AMI. Contractile reserve can be rapidly identified by echo cardiography and is specific, but moderately sensitive for predicting reversible dysfunction.
Disciplines :
Cardiovascular & respiratory systems
Author, co-author :
PIERARD, Luc ; Centre Hospitalier Universitaire de Liège - CHU > Cardiologie
MELON, Pierre ; Centre Hospitalier Universitaire de Liège - CHU > Cardiologie
Degueldre, Christian ; Université de Liège - ULiège > Centre de recherches du cyclotron
Kulbertus, HE
Language :
English
Title :
Identification of viable myocardium early after acute myocardial infarction using closed-loop arbutamine echocardiography: comparison with positron emission tomography
Piérard L.A., De Landsheere C.M., Berthe C., Rigo P., Kulbertus H.E. (1990) Identification of the viable myocardium during dobutamine infusion in patients with myocardial infarction after thrombolytic therapy: Comparison with positron emission tomography. J Am Coll Cardiol 15:1021-1031.
Smart S.C., Sawada S., Ryan T., Segar D., Atherton L., Berkovitz K., Bourdillon P.D., Feigenbaum H. (1993) Low-dose dobutamine echocardiography detects reversible dysfunction after thrombolytic therapy of acute myocardial infarction. Circulation 88:405-411.
Watada H., Ito H., Oh H., Masuyama T., Aburaya H., Hori M., Iwakura M., Higashino Y., Fujii K. (1994) Dobutamine stress echocardiography predicts reversible dysfunction and quantitates the extent of irreversibly damaged myocardium after reperfusion of anterior myocardial infarction. J Am Coll Cardiol 24:624-630.
Young M., Pan W., Wiesner J., Bullough D., Browne G., Balow G. (1994) Characterization of arbutamine: A novel catecholamine stress agent for diagnosis of coronary artery disease. Drug Dev Res 32:19-28.
Hammond H.K., McKirnan M.D. (1994) Effects of dobutamine and arbutamine on regional myocardial function in a porcine model of myocardial ischemia. J Am Coll Cardiol 23:475-482.
Kiat H., Iskandrian A.S., Villegas B.J., Starling M.R., Berman D.S. (1995) Arbutamine stress thallium-201 single-photon emission computed tomography using a computerized closed-loop delivery system. Multicenter trial for evaluation of safety and diagnostic accuracy. J Am Coll Cardiol 26:1159-1167.
Cohen J.L., Chan K.L., Jaarsma W., Bach D.S., Muller D.W.M., Starling M.R., Armstrong W.F. (1995) Arbutamine echocardiography: Efficacy and safety of a new pharmacologic stress agent to induce myocardial ischemia and detect coronary artery disease. J Am Coll Cardiol 26:1168-1175.
Sklenar J., Camarano G., Goodman C., Ismail S., Jayaweera A.R., Kaul S. (1996) Contractile versus microvascular reserve for the determination of the extent of myocardial salvage after reperfusion. The effect of residual coronary stenosis. Circulation 94:1430-1440.
Kaul S. (1995) There may be more to myocardial viability than meets the eye!. Circulation 92:2790-2793.
Sabbah H.N., Marzilli M., Stein P.D. (1981) The relative role of subendocardium and subepicardium in left ventricular mechanics. Am J Physiol 240.
Bolognese L., Cerisano G., Buonamici P., Santini A., Santoro G.M., Antoniucci D., Fazzini P.F. (1997) Influence of infarct-zone viability on left ventricular remodeling after acute myocardial infarction. Circulation 96:3353-3359.
Schulz R., Heusch G. (1995) Characterization of hibernating and stunned myocardium. Eur Heart J 16(SUPPL. J):19-25.
Marinho N.V.S., Keogh B.E., Costa D.C., Lammerstma A.A., Ell P.J., Camici P.G. (1996) Pathophysiology of chronic left ventricular dysfunction: New insights from the measurement of absolute myocardial blood flow and glucose utilization. Circulation 93:737-744.
Gerber B.L., Vanoverschelde J.L., Bol A., Michel C., Labar D., Wijns W., Melin J.A. (1996) Myocardial blood flow, glucose uptake, and recruitment of inotropic reserve in chronic left ventricular ischemic dysfunction. Implications for the pathophysiology of chronic myocardial hibernation. Circulation 94:651-659.
Lee H.H., Davila-Roman V.G., Ludbrook P.A., Courtois M., Walsh J.F., Delano D.A., Rubin P.J., Gropler R.J. (1997) Dependency of contractile reserve on myocardial blood flow. Implications for the assessment of myocardial viability with dobutamine stress echocardiography. Circulation 96:2884-2891.
Chen C., Chen L., Fallon J.T., Ma L., Li L., Bow L., Knibbs D., McKay R., Gillam L.D., Waters D.D. (1996) Functional and structural alterations with 24-hour myocardial hibernation and recovery after reperfusion. A pig model of myocardial hibernation. Circulation 94:507-516.
Salustri A., Elhendy A., Garyfallydis P., Ciavatti M., Cornel J.H., Ten Cate F.J., Boersma E., Gemelli A. (1994) Prediction of improvement of ventricular function after first acute myocardial infarction using low-dose dobutamine stress echocardiography. Am J Cardiol 74:853-856.
